UK Medical Cannabis Prescriptions Surpass 150,000 Active Patients

The UK medical cannabis market has passed a major milestone with the total number of active patient prescriptions surpassing 150,000. The figure represents extraordinary growth from the early years following rescheduling and signals that medical cannabis has moved from a niche treatment to a mainstream option for patients with a wide range of conditions.

Growth in Context

When the UK government rescheduled cannabis-based medicines in November 2018, the initial rollout was cautious and prescribing was limited to a narrow set of severe conditions. The subsequent years have seen a gradual but accelerating expansion of both the evidence base and clinical confidence, resulting in a steady increase in patient numbers across all major condition categories.

• Chronic pain remains the single largest category of treated condition
• Mental health indications including anxiety and PTSD are the fastest-growing segment
• Neurological conditions including MS and epilepsy represent a stable but significant proportion
• Cancer-related symptoms and insomnia are among other commonly treated conditions

What Drives Patient Growth

Multiple factors contribute to the increasing patient numbers. Greater awareness among patients and GPs, a wider range of approved products, improved cost accessibility, a larger clinic network, and a growing clinical evidence base have all played a role. Patient communities and advocacy groups have also been effective in sharing information and reducing the stigma sometimes associated with seeking a medical cannabis prescription.

For anyone considering whether medical cannabis is right for them, our condition guides and prescription guide are a good starting point. You can also explore available products in our strain directory and locate a local specialist through our clinic finder.